delamanid,
OPC-67683,
Delamanid,
681492-22-8,
OPC-67683,
UNII-8OOT6M1PC7,
8OOT6M1PC7,
MMV688262,
(R)-2-Methyl-6-nitro-2-((4-(4-(4-(trifluoromethoxy)phenoxy)piperidin-1-yl)phenoxy)methyl)-2,3-dihydroimidazo[2,1-b]oxazole,
(2R)-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenoxy]methyl]-3H-imidazo[2,1-b][1,3]oxazole,
(R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole,
(2R)-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]phenoxy]methyl]-3H-imidazo[2,1-b]oxazole,
(R)-2-methyl-6-nitro-2-(4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole,
Deltyba (TN),
OPC 67683,
Delamanid (JAN/USAN),
AC1O59GP,
OPC-67683; Delamanid,
SCHEMBL57791,
Delamanid (OPC-67683),
Delamanid [USAN:INN:JAN],
CHEMBL218650,
KS-00001CTL,
DTXSID60218326,
CHEBI:134742,
XDAOLTSRNUSPPH-XMMPIXPASA-N,
BCP07838,
EX-A2414,
MFCD18251539,
ZINC43100810,
AKOS025289781,
ACN-053049,
CS-5866,
SB14863,
NCGC00348214-01,
(2R)-2-Methyl-6-nitro-2-((4-(4-(4-(trifluoromethoxy)phenoxy)piperidin-1- yl)phenoxy)methyl)-2,3-dihydroimidazo(2,1-b)oxazole,
AK171339,
HY-10846,
Imidazo(2,1-b)oxazole, 2,3-dihydro-2-methyl-6-nitro-2-((4-(4-(4-(trifluoromethoxy)phenoxy)-1-piperidinyl)phenoxy)methyl)-, (2R)-,
D09785,
(2R)-2,3-Dihydro-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidinyl]phenoxy]methyl]imidazo[2,1-b]oxazole,
(2R)-2-Methyl-6-nitro-2-[4-[4-[4-(trifluoromethoxy)phenoxy]piperidino]phenoxymethyl]-2,3-dihydroimidazo[2,1-b]oxazole,
[(2R)-2-methyl-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]phenoxy]methyl]-3H-imidazo[2,1-b]oxazol-6-yl]azinic acid,
2-Methyl-6-nitro-2-[(4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl}phenoxy)methyl]-2,3-dihydroimidazo[2,1-b]oxazole, (2R)-,
deltyba,
Delamanid [USAN],
Delamanid [USAN:INN],
D0S3NU,
AIDS182259,
CID6480466,
A12864,
C516022,
2-nitroimidazole derivatives (tuberculosis), Otsuka,
Nitro-dihydroimidazo-oxazole derivatives (tuberculosis), Otsuka,